Vascular endothelial growth factor accelerates compensatory lung growth after unilateral pneumonectomy.

We hypothesize that compensatory lung growth after unilateral pneumonectomy in a murine model is, in part, angiogenesis dependent and can be altered using angiogenic agents, possibly through regulation of endothelial cell proliferation and apoptosis. Left pneumonectomy was performed in mice. Mice were then treated with proangiogenic factors [vascular endothelial growth factor (VEGF); basic fibroblast growth factor (bFGF)], VEGF receptor antibodies (MF-1, DC101), and VEGF receptor small molecule chemical inhibitors. Lung volume and mass were measured. The lungs were analyzed using immunohistochemistry by CD31 staining, terminal deoxynucleotidyl transferase biotin-dUTP nick end labeling, type II pneumocytes staining, and proliferating cell nuclear antigen. Compensatory lung growth was complete by postoperative day 10 and was associated with diffuse apoptosis of endothelial cells and pneumocytes. This process was accelerated by VEGF, such that growth was complete by postoperative day 4 with similar associated apoptosis. bFGF had no effect on lung growth. MF-1 and DC101 had no effect. The VEGF receptor small molecule chemical inhibitors also had no effect. VEGF, but not bFGF, accelerates growth. VEGF receptor inhibitors do not block growth, suggesting that other proangiogenic factors play a role or can compensate for VEGF receptor blockade. Diffuse apoptosis, endothelial cell and pneumocyte, occurs at cessation of both normal compensatory and VEGF-accelerated growth. Angiogenesis modulators may control growth via regulation of endothelial cell proliferation and apoptosis, although the exact relationship between endothelial cells and pneumocytes has yet to be determined. The fact that bFGF did not accelerate growth in our model when it did accelerate regeneration in the liver model suggests that angiogenesis during organ regeneration is regulated in an organ-specific manner.

[1]  T. L. Le Cras,et al.  Vascular growth and remodeling in compensatory lung growth following right lobectomy. , 2005, Journal of applied physiology.

[2]  D. Fauza,et al.  Pneumonectomy in the Mouse: Technique and Perioperative Management , 2005, Journal of investigative surgery : the official journal of the Academy of Surgical Research.

[3]  Susan M. Kilroy,et al.  Urinary Matrix Metalloproteinases and their Endogenous Inhibitors Predict Hepatic Regeneration after Murine Partial Hepatectomy , 2004, Transplantation.

[4]  David M Jablons,et al.  Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  J. Davies,et al.  Targeting angiogenesis with a conjugate of HPMA copolymer and TNP-470 , 2004, Nature Medicine.

[6]  E. Szmit,et al.  The effect of angiogenesis inhibitor TNP-470 on the blood vessels of the lungs, kidneys and livers of treated hamsters. , 2004, Folia morphologica.

[7]  M. Musumeci,et al.  Video-assisted orotracheal intubation in mice , 2003, Laboratory animals.

[8]  A. Luttun,et al.  Placental growth factor and its receptor, vascular endothelial growth factor receptor‐1: novel targets for stimulation of ischemic tissue revascularization and inhibition of angiogenic and inflammatory disorders , 2003, Journal of thrombosis and haemostasis : JTH.

[9]  J. Folkman,et al.  Endothelial-Directed Hepatic Regeneration After Partial Hepatectomy , 2003, Annals of surgery.

[10]  P. Hahnfeldt,et al.  Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn't tell us. , 2002, Journal of the National Cancer Institute.

[11]  Wadih Arap,et al.  In vivo phage display and vascular heterogeneity: implications for targeted medicine. , 2002, Current opinion in chemical biology.

[12]  Simon C Watkins,et al.  Spatiotemporal expression of angiogenesis growth factor receptors during the revascularization of regenerating rat liver , 2001, Hepatology.

[13]  S. Rafii,et al.  Impaired recruitment of bone-marrow–derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth , 2001, Nature Medicine.

[14]  K. Goss,et al.  VEGF induces airway epithelial cell proliferation in human fetal lung in vitro. , 2001, American journal of physiology. Lung cellular and molecular physiology.

[15]  N. Assy,et al.  Vascular endothelial growth factor and angiopoietin in liver regeneration. , 2001, Biochemical and biophysical research communications.

[16]  S. Rannels,et al.  Implications of post-pneumonectomy compensatory lung growth in pulmonary physiology and disease , 2001, Respiratory research.

[17]  C. Jaime,et al.  Molecular mechanics (MM3) study of the conformations of ethyl esters of diastereoisomeric 3-substituted 4,4,4-trichloro-2-cyano-butanoic acids , 2001 .

[18]  M. Miyazaki,et al.  Vascular endothelial growth factor secreted by replicating hepatocytes induces sinusoidal endothelial cell proliferation during regeneration after partial hepatectomy in rats. , 2001, Journal of hepatology.

[19]  C. Tribble,et al.  Retinoic acid enhances lung growth after pneumonectomy. , 2001, The Annals of thoracic surgery.

[20]  H. Reynaert,et al.  Vascular endothelial growth factor and liver regeneration. , 2001, Journal of hepatology.

[21]  T. Sato,et al.  Sinusoidal endothelial cell proliferation and expression of angiopoietin/Tie family in regenerating rat liver. , 2001, Journal of hepatology.

[22]  R. Crystal,et al.  Compartmentalization of Vascular Endothelial Growth Factor to the Epithelial Surface of the Human Lung , 2001, Molecular medicine.

[23]  H. Farber,et al.  VEGF is deposited in the subepithelial matrix at the leading edge of branching airways and stimulates neovascularization in the murine embryonic lung , 2000, Developmental dynamics : an official publication of the American Association of Anatomists.

[24]  Philip Hahnfeldt,et al.  Cancer: looking outside the genome , 2000, Nature Reviews Molecular Cell Biology.

[25]  N. Voelkel,et al.  Inhibition of angiogenesis decreases alveolarization in the developing rat lung. , 2000, American journal of physiology. Lung cellular and molecular physiology.

[26]  H. Nguyen,et al.  Stretch-induced upregulation of VEGF gene expression in murine pulmonary culture: a role for angiogenesis in lung development. , 2000, Journal of pediatric surgery.

[27]  P. Hahnfeldt,et al.  Tumor development under angiogenic signaling: a dynamical theory of tumor growth, treatment response, and postvascular dormancy. , 1999, Cancer research.

[28]  J. Klekamp,et al.  Exposure to hyperoxia decreases the expression of vascular endothelial growth factor and its receptors in adult rat lungs. , 1999, The American journal of pathology.

[29]  R Pasqualini,et al.  Molecular heterogeneity of the vascular endothelium revealed by in vivo phage display. , 1998, The Journal of clinical investigation.

[30]  Erkki Ruoslahti,et al.  Organ targeting In vivo using phage display peptide libraries , 1996, Nature.

[31]  L. Naldini,et al.  Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth , 1992, The Journal of cell biology.

[32]  D. Ingber,et al.  Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth , 1990, Nature.

[33]  W. Scherle,et al.  A simple method for volumetry of organs in quantitative stereology. , 1970, Mikroskopie.

[34]  Chen Hongbing,et al.  Association of insulin-like growth factors with lung development in neonatal rats , 2008, Journal of Huazhong University of Science and Technology [Medical Sciences].

[35]  A. Bikfalvi,et al.  Tumor angiogenesis , 2020, Advances in cancer research.

[36]  R. D'Amato,et al.  Genetic heterogeneity of the vasculogenic phenotype parallels angiogenesis; Implications for cellular surrogate marker analysis of antiangiogenesis. , 2005, Cancer cell.

[37]  Wenbin Li,et al.  Association of insulin-like growth factors with lung development in neonatal rats. , 2004, Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban.

[38]  P. Carmeliet,et al.  Loss of HIF-2α and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice , 2002, Nature Medicine.

[39]  B. Moats-Staats,et al.  Regulation of the insulin-like growth factor system during normal rat lung development. , 1995, American journal of respiratory cell and molecular biology.